Medifast, Inc. Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Medifast (MED) Tops Q2 EPS by 65c
August 4, 2021 4:46 PM EDTMedifast (NYSE: MED) reported Q2 EPS of $3.96, $0.65 better than the analyst estimate of $3.31. Revenue for the quarter came in at $394.2 million versus the consensus estimate of $358.45 million.
GUIDANCE:
Medifast sees Q3 2021 EPS of $12.70-$14.17, versus the consensus of $13.80. Medifast sees Q3 2021... More
